Skip to main content
OpenTrials

Clinical trial condition

Advanced Ovarian Cancer

Explore clinical trials studying Advanced Ovarian Cancer. Study availability and eligibility vary by location and protocol.

24 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Advanced Ovarian Cancer trial results

Completed

Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin

NCT03161132

Conditions
Advanced Ovarian Cancer
Locations
  • Corporación Sanitaria Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Universitario de Gran Canaria Doctor Negrín Las Palmas de Gran Canaria, Gran Canaria, Spain
  • Hospital Son Llatzer Palma de Mallorca, Mallorca, Spain
  • Hospital Universitario Ramón y Cajal Madrid, Spain
View Trial Details
Completed

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

NCT01290471

Conditions
Advanced Ovarian Cancer, Advanced Solid Malignant Tumors
Locations
  • Karmanos Cancer Center Detroit, Michigan, United States
  • Univ. Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

NCT03737643

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
Locations
  • Research Site Foothill Ranch, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site San Francisco, California, United States
View all 214 locations
View Trial Details

Related conditions